German HealthTech company Aiomics has successfully closed a €2 million pre-Seed financing round to expand its platform, scale to diverse care settings and prepare for entry into additional European markets.
The round was led by Vorwerk Ventures, with participation from Calm/Storm, Norrsken Evolve, and Rule30. Several renowned business angels also joined the round, including Konstantin Othmer, Nicolas Weber, Andrea Kranzer and Markus Wild.
“The clinical software landscape is undergoing a fundamental transformation: artificial intelligence is driving the unbundling of existing systems. Unlike traditional software, AI can adapt much more granularly to the individual realities of different hospitals, departments, and specialties. This enables solutions like Aiomics to integrate faster and more seamlessly – with enormous potential for European healthcare,” said Sascha Günther, Partner at Vorwerk Ventures.
Aiomics was founded in 2025 by Dr Sven Jungmann, Dr Nikita Tarasov, and Kirill Schitomirski. The company is working with (as of yet unannounced) leading healthcare institutions.
Aiomics’ mission is to relieve the healthcare system by reducing administrative overhead and supporting the daily work of clinicians, nurses, and therapists with validated, structured, and workflow-guiding data.
Aiomics develops an AI-powered documentation platform for healthcare designed to relieve doctors, nurses, and therapists from time-consuming administrative work. The solution captures speech, handwriting, and documents in a single validated workflow, checks completeness and consistency via a human-in-the-loop process, and delivers structured, coded, and audit-secure data back into existing systems.
This allegedly reduces errors, accelerates reimbursements, and frees medical staff to focus more on patient care.
With the fresh capital, Aiomics plans to further expand its platform, scale to diverse care settings – from acute hospitals and rehabilitation centers to telemedicine providers – and prepare for entry into additional European markets.
Aiomics’ funding round was included in EU-Startups’ coverage of Norrsken Evolve; a €57 million fund aimed at investing in early-stage, impact-driven companies across Europe. Aiomics was amonth the portfolio companies announced with the fund.
Read the orginal article: https://www.eu-startups.com/2025/09/berlins-aiomics-secures-e2-million-to-free-europes-healthcare-from-documentation-burdens/
